The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol

被引:5
作者
Jennings, FW
Atouguia, JM
Murray, M
机构
[1] UNIV GLASGOW,DEPT VET CLIN STUDIES,GLASGOW G61 1QH,LANARK,SCOTLAND
[2] INST HYG & TROP MED,LISBON,PORTUGAL
关键词
melarsoprol; cymelarsan; melarsen oxide; dimercaptopropinol (bal); topical gel;
D O I
10.1016/S0001-706X(96)00036-8
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Both melarsomine dichlorhydrate (mel Cy, Cymelarsan(R)) and melarsen oxide can be dissolved in dimethylsulfoxide and converted into a gel by the addition of hydroxypropylcellulose. When Trypanosoma brucei brucei-infected mice are treated topically with these gels the circulating trypanosomes are rapidly cleared from the circulation but the infections relapse soon after the last application. However, when these two compounds are allowed to react with 2,3-dimercaptopropinol (British anti-lewisite, BAL) and form ''melarsoprol'' their efficacy, especially in the case of mel Cy, is restored to that of commercial melarsoprol (Arsobal(R)) and trypanosomes in the central nervous system (CNS) can be eliminated. This would indicate that the dimercaptopropinol portion of the molecule does not act solely as an ''antidote'' to arsenic toxicity, but also plays an important role in the absorption of melarsoprol through the skin and/or blood-brain barrier into the CNS and/or into the trypanosome.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 5 条
[1]   SUCCESSFUL TREATMENT OF EXPERIMENTAL MURINE TRYPANOSOMA-BRUCEI INFECTION WITH TOPICAL MELARSOPROL GEL [J].
ATOUGUIA, JM ;
JENNINGS, FW ;
MURRAY, M .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (05) :531-533
[2]   PROPERTIES OF MELARSAMINE HYDROCHLORIDE (CYMELARSAN) IN AQUEOUS-SOLUTION [J].
BERGER, BJ ;
FAIRLAMB, AH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1298-1302
[3]  
Jennings F W, 1983, Contrib Microbiol Immunol, V7, P147
[4]   COMBINATION CHEMOTHERAPY OF CNS TRYPANOSOMIASIS [J].
JENNINGS, FW .
ACTA TROPICA, 1993, 54 (3-4) :205-213
[5]   RISK-FACTORS FOR ENCEPHALOPATHY AND MORTALITY DURING MELARSOPROL TREATMENT OF TRYPANOSOMA-BRUCEI-GAMBIENSE SLEEPING SICKNESS [J].
PEPIN, J ;
MILORD, F ;
KHONDE, AN ;
NIYONSENGA, T ;
LOKO, L ;
MPIA, B ;
DEWALS, P .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (01) :92-97